
News from International Cannabis Business Conference | Vancouver – Berlin – SF – Portland…
Information about International Cannabis Business Conference | Vancouver – Berlin – SF – Portland…
Where is International Cannabis Business Conference | Vancouver – Berlin – SF – Portland… located?International Cannabis Business Conference | Vancouver – Berlin – SF – Portland…'s WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top International Cannabis Business Conference | Vancouver – Berlin – SF – Portland… News

Psychedelics · CzechiaLawmakers in the Czech Republic have passed a bill to reform the nation’s drug laws by legalizing simple possession and home cultivation of marijuana and allowing the use of psilocybin for medical purposes. One month after the Chamber of Deputies approved the legislation, the Senate gave it final approval on Thursday. It now heads to the desk of President Petr Pavel to be signed into law. The drug policy reforms are part of a package of amendmen…See the Story
Czech Republic Bill To Legalize Marijuana Home Cultivation And Allow Psilocybin For Medical Use Heads To President’s Desk
100% Left coverage: 1 sources

Parkinson's DiseaseGlycoprotein nonmetastatic melanoma protein B (GPNMB) is a glycosylated type I transmembrane protein that forms soluble GPNMB upon maturation. This study aimed to explore the relationship between plasma GPNMB levels in patients with Parkinson’s disease (PD) and their clinical manifestations, as well as their correlations with specific brain regions identified through imaging analysis. This study included patients with PD and healthy control subj…See the Story
Increased Plasma GPNMB Levels in Patients with Parkinson’s Disease and Cognitive Impairment
100% Center coverage: 1 sources